标题
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?
作者
关键词
-
出版物
Future Oncology
Volume 13, Issue 8, Pages 673-677
出版商
Future Medicine Ltd
发表日期
2017-02-10
DOI
10.2217/fon-2016-0519
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma
- (2016) Marilù Fanelli et al. CURRENT CANCER DRUG TARGETS
- H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance
- (2016) Konstantin Chegaev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial
- (2016) Sophie Piperno-Neumann et al. LANCET ONCOLOGY
- Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
- (2016) I. Buondonno et al. MOLECULAR CANCER THERAPEUTICS
- An injectable nanoparticle generator enhances delivery of cancer therapeutics
- (2016) Rong Xu et al. NATURE BIOTECHNOLOGY
- Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance
- (2015) Yuanyuan Zhao et al. ACS Applied Materials & Interfaces
- Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?
- (2015) Leo Kager et al. Expert Opinion on Drug Metabolism & Toxicology
- Advances in emerging drugs for osteosarcoma
- (2015) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma
- (2015) David A. Liebner JOURNAL OF SURGICAL ONCOLOGY
- Pharmacokinetic study of aldoxorubicin in patients with solid tumors
- (2014) Monica M. Mita et al. INVESTIGATIONAL NEW DRUGS
- Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance
- (2014) Valeria Sero et al. INVESTIGATIONAL NEW DRUGS
- A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity
- (2014) A. Maksimenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
- (2013) E Tavanti et al. BRITISH JOURNAL OF CANCER
- A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma
- (2013) K.A. Thornton et al. INTERNATIONAL JOURNAL OF CANCER
- Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Yu-Cai Wang et al. BIOCONJUGATE CHEMISTRY
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
- (2011) Anna Brózik et al. Expert Opinion on Drug Metabolism & Toxicology
- Emerging drugs for high-grade osteosarcoma
- (2010) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- ABC Transporters as Potential Targets for Modulation of Drug Resistance
- (2009) L. Gatti et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now